|
Overview
COVID 19 (Coronavirus) pandemic has affected almost all countries and has made a significant effect on the available healthcare facilities and treatment systems. It has created a surge demand for essential healthcare equipment, medicines along with the requirement for advance information technologies applications. Digital healthcare is a powerful element which can be extremely useful against the pandemic of COVID-19 regarding the assessment of risks of infection and screening of population. Today, multiple digital health projects based on artificial intelligence data science, ‘machine learning‘ or ‘big data’, are being used across a broad range of fields to predict, explain and manage the different scenarios caused by the health crisis. Moving forward, as many health systems begin to emerge from lockdown and assess the financial impact of these past few months, AI-driven analytics will be essential to driving cost efficiencies. Join us in the upcoming half day online event that will bring together key leaders in digital healthcare to discuss on the strategies that can be used to innovate and roll out digital healthcare against the COVID-19 pandemic. |
Who Should Attend
Directors, VPs/Heads Managers and other Senior Level Executive dealing with:
From the following organizations:
|
Keynote Address
|
YB DATO’ DR NOOR AZMI BIN GHAZALI Deputy Minister Of Health Malaysia |
SPEAKERS
Dr Lo Ying-Ru Jacqueline
Head of Mission and WHO Representative to Malaysia, Brunei Darussalam and Singapore World Health Organization (WHO) |
Dr Lo Ying-Ru Jacqueline is a board certified physician (Internal Medicine, Tropical Medicine and Hygiene) from Hamburg, Germany who took up her duties at the World Health Organization (WHO) in 1998. With over three decades of work experience as a clinician and public health adviser, Dr Lo has worked in Europe, Latin America, and Asia and has held positions at all three levels of the Organization. Dr Lo’s particular interest lies in translating research into implementation. Dr Lo is heading the WHO Office for Malaysia, Brunei Darussalam and Singapore. She leads the high-level strategic and policy dialogue with the Ministries of Health. |
Frank Hester OBE,
Founder and CEO TPP, UK Digital Health Company |
Frank has always been at the forefront of IT innovation. He founded TPP in 1997 to create technology that makes life easier for the doctors. Frank has pioneered integrated care and digital health, creating software that helps transform healthcare worldwide. The software that Frank created is now used in over 7000 organisations in the UK and in other deployments across the Middle East, Caribbean and China. During the Covid-19 pandemic, TPP has been at the forefront of the UK digital response, providing invaluable support to frontline staff in the National Health Service (NHS). The company has also played a key part in medical research into Covid-19 by harnessing the data created across the 50million+ Electronic Medical Records (EMRs) in its UK database. Frank led the TPP team that collaborated with institutions including the University of Oxford, the London School of Hygiene and Tropical Medicine and UK Biobank. He has co-authored several very high-profile research papers during the crisis, helping to support understanding, policy and response. |
Professor Michael Baker,
Department of Public Health University of Otago, New Zealand |
Michael Baker is a public health physician, Professor of Public Health, and acting Head of the Department of Public Health at the University of Otago, Wellington. He is a member of the Ministry of Health’s Covid-19 Technical Advisory Group (TAG) and has taken a leading role in formulating New Zealand’s elimination strategy against this pandemic. Michael is the Director of the Health Environment and Infection Research Unit (HEIRU) and a Co-Director of the Housing and Health Research Programme. He has long-standing research interests in infectious diseases, environmental health, and housing and health. He is an active media commentator and member of the Science Media Centre Advisory Board. |
Dr Claudia Abreu Lopes
Research Fellow United Nations University International Institute for Global Health (UNU-IGH) |
Dr Claudia Abreu Lopes is a Research Fellow at the United Nations University International Institute for Global Health (UNU-IIGH). She has spent 20 years in academia with positions at the Faculty of Psychology at the University of Coimbra (Portugal), Institute of Social Psychology at the London School of Economics and Political Science (LSE), and Department of Politics and International Studies at the University of Cambridge (POLIS). Prior to joining UNU, she was an Affiliated Lecturer in Statistics and Methods at POLIS and a Lead Consultant in Big Data and Gender at UN Women. Claudia has also worked on the charity sector with Girl Effect (Data Scientist), and Africa’s Voices Foundation (Head of Research and Innovation), leading projects that used digital data to accelerate and evaluate the impact of public health interventions. She was also involved in evaluations for the World Bank, BBC Media Action and GPSDD. Her research interests focus on methodologies that use big data as a complement to official statistics to monitor and advance sustainable development goals related to gender equality and health. She has been applied them to projects related to adolescent sexual and reproductive health and violence against women and girls. She is also interested in the structural determinants of health inequalities and their impact on health outcomes. She holds a PhD in Social Research Methods from the LSE, a Master’s degree in Social Psychology from the University of Porto, a Degree of Advanced Studies in Social Psychology awarded by the University of Geneva and the University of Bari, and a Licentiate degree in Psychology from the University of Coimbra. |
Dr Helmi Zakariah
Chief Executive Officer AIME INC, Malaysia Selangor COVID-19 Task Force, Malaysia |
Dr Helmi Zakariah begins his journey in Big Data Analytics & Digital Epidemiology as the Chief Executive Officer of AIME & AI4Good, where he led the delivery of data analytics solution in public health, women & reproductive health, and sustainable agriculture across 3 continents. In Nov 2019, Dr Helmi Zakariah was appointed as a member of the WHO/ITU Working Group for AI in Outbreak, a multi-institutional and global platform aim to leverage on Machine Learning to mitigate outbreaks. When the Covid19 pandemic reached Malaysia, he was tasked to lead the Digital Epidemiology portfolio for the Selangor State Task Force for Covid19 – the most densely populated state in Malaysia. He started off his career in Public Health as a district program manager for National Tuberculosis Control Programme. Subsequently in the Ministry of Health Malaysia, he co-pioneered the establishment of Global Health Division and oversees Malaysia engagement with global health entity such as the WHO, MSF, ASEAN, UNHCR, IOM and the Union of International Cancer Control, over various topic area such as International Disease Control, Migrant Health and Trade Impact on Public Health. Dr Helmi Zakariah had his early education holds a Medical Degree from Russian Federation with a Master in International Public Health from University of Liverpool, the United Kingdom. He regularly share his thought as speakers through global cooperative platform such as Chatham House, World Economic Forum, and Commonwealth Digital Health Forum. |
Professor Patrick Brennan, PhD
CEO, DetectED-X University of Sydney |
Professor Brennan is the world’s most published Medical Radiation Scientist. His publications involve exploring novel technologies and techniques that enhance the detection of clinical indicators of disease, whilst minimizing risk to the patient. He is recognized as a leader in clinical translation of medical imaging optimization and radiological perception. His research has been disseminated through 35 keynote/plenary talks across 5 continents and he has presented at the major international imaging meetings including the annual meetings of the Radiological Society of North America, European Congress, UK Radiological Congress, International Society of Optical Engineering and Medical Imaging Perception Society. He is the recipient of 20 highly prestigious awards. |
Professor Datuk Dr. A.Rahman A.Jamal
Head of Taskforce for MOSTI-MOHE COVID-19 Testing Laboratories |
Professor Datuk Dr. A Rahman A Jamal is a professor of paediatric haematology, oncology and molecular biology at Universiti Kebangsaan Malaysia. He is the Pro Vice Chancellor of the UKM’s Kuala Lumpur Campus. He was the founding director (2003-2017) and now a senior principal research fellow of the UKM Medical Molecular Biology Institute (UMBI). He is also an honorary professor at the University of Dundee, Scotland, UK. He is the project leader for The Malaysian Cohort and the Cohort Biobank, the largest in South-East Asia. He was the project director for the UKM Specialist Children’s Hospital (2010-2019). His research interests include cancers, other non-communicable diseases, and cohort studies. He has over 200 indexed publications. One of his latest projects is The Cancer Genome Atlas Malaysia. He is involved in two MRC UK-Malaysia research projects on diabetes and obesity.He is the chairman of National Stem Cell Committee for Ethics in Research and Therapy, Ministry of Health (MOH), a committee member for the Thalassaemia Control Programme (MOH), and member of the National Clinical Trials Committee MOH. He is a fellow of the Academy Sciences of Malaysia and heads a task force for a Precision Medicine Initiative. He is a board member for the Clinical Research Malaysia Sdn Bhd and UKM Kesihatan Berhad. He is a member of the Asia Cohort Consortium, Committee for Longitudinal Population Studies (Welcome Trust UK), International 100K Cohort Consortium, and the International Commission for Human Germline Genome Editing (National Academy of Sciences USA and Royal Society UK). He has given more than 170 invited lectures including plenary and keynote lectures. During the Covid-19 pandemic, he was the chairman of the task force for the MOHE-MOSTI collaboration to set up Covid-19 testing labs in the universities to help increase the capacity of testing of MOH samples. |
Datuk Dr Kuljit Singh
Medical Director Prince Court Medical Centre |
Datuk Dr. Kuljit Singh earned his Master’s in Otorhinolaryngology from University Malaya, Kuala Lumpur in 2002. Prior to that, he served at Hospital Kuala Lumpur & Hospital Kangar, as the ENT Clinical specialist in HKL [2002], Lecturer & ENT Specialist at University Malaya Medical Centre (UMMC) and now Consultant ENT Surgeon at Prince Court Medical Centre (PCMC) since 2007. Currently, he serves the position of Medical Director at PCMC, Kuala Lumpur, Malaysia and is also the President of Association Private Hospitals Malaysia (APHM). His passion is to serve towards the healthcare of the people of this country. |
Dr. Snehal Patel
Chief Executive Officer & Co-founder |
Dr. Patel moved to Singapore from the US in 2008 to found and lead the healthcare team at the Chandler Corporation, a multi-billion dollar investment fund. Prior to practising law at Cravath, Swaine & Moore, LLP in New York, Dr Patel received an MD and a JD from Columbia University and served as a Clinical Fellow at the Harvard Medical School. |
Dr. Md. Khadzir bin Sheikh Hj. Ahmad
Deputy Director & Head of the Health Informatics Centre Ministry of Health, Malaysia |
Md Khadzir is the Head of the Health Informatics Centre, Ministry of Health, Malaysia. He is a certified Occupational Health Physician and received his Medical Degree from National University of Malaysia, Master Degree in Occupational Medicine from the National University of Singapore and PhD Degree in Occupational Health from the University of Birmingham, UK. He had been drafting Health Laws; Medical Ethics and instrumental in initiating the Traditional and Complementary Medicine Services in the pioneer Hospital Kepala Batas, Hospital Putrajaya and Hospital Sultan Ismail. The program includes registration of Traditional and Complementary Medicine practitioner in Malaysia. He has been heading the development and operation of electronic Health Information and Management System and the development of Health Informatics Standards for Malaysia since late 2008.
He is now leading the development of Malaysian Health Data Warehouse, the project was developed using more than 90 percent local technology; was rolled out in August 2016 and launched by the Health Minister in April 2017. The Data Warehouse collects and analyzed visit data of all individuals visiting any healthcare facilities and managed structured and unstructured data. The analytic result are presented in either fixed format report; dashboard; ad-hoc query; and in Geographic Information System (GIS). The emphasis of the project has been on quality data with overarching privacy and security of data and information in place. The project is now moving into Big Data Analytics with emphasis on more data sources and predictive analytics. |
Dr Chris Bates
Director of Research and Analytics TPP UK Digital Health Company |
Chris is a data scientist and developer at TPP and holds a PhD in Mathematics from the University of Manchester. Chris leads TPP’s work in the use of EHR data to support analytics, research, and surveillance. He has previously been recognised by the Health Service Journal (HSJ) as one of the top 50 innovators in UK healthcare.
In recent years, Chris led the TPP team which contributed to the development of the national Electronic Frailty Index (eFI). He is involved in a number of national research programmes, including in cancer survivorship and antimicrobial resistance. He works closely with the UK Biobank team, helping to combine EHR data with genomic information to support their vital research. Chris also has a strong interest in clinical terminologies and open standards for interoperability. He has spoken on many digital health topics at large conferences, including at both SNOMED CT Expos and at Health Datapalooza in the US. He is an active researcher and has co-authored a number of academic papers in prominent journals, such as Science. As part of TPP’s response to the Covid-19 pandemic, Chris has been a key member of the OpenSAFELY collaborative and has helped build a large, secure platform for national Covid-19 research. He is also leading TPP’s support of the PRINCIPLE trial at the University of Oxford, aiming to discover whether selected treatments can improve Covid-19 outcomes. |
Agenda, 16th July 2020
14:00 PM Opening Keynote Remarks from Ministry of Health Malaysia
YB DATO’ DR NOOR AZMI BIN GHAZALI, Deputy Minister Of Health, Malaysia
14:20 PM The Impact of COVID-19 on Society and the Way Artificial Intelligence can be Leveraged in the Battle Against the Virus
- Diagnostic and quantitative screening of COVID-19 cases through AI based algorithms
- Tracking the high-risk subsets likely to be infected with COVID-19
- Customizing medical care and follow-up plans to get better results
14:50 PM Panel Discussion: Lessons Learnt from Successful Models in Controlling the Spread of COVID-19 Pandemic
- Analyzing countries that have successfully adapted to COVID-19, and why some still struggle to flatten the curve?
- How effective can a test-and-trace policy really be in containing future waves of infection?
- What social distancing measures might still be needed to enhance containment?
- The major role of local communities in the battle against COVID-19
Panellists:
Dr Lo Ying-Ru, Head of Mission and WHO Representative to Malaysia, Brunei Darussalam and Singapore, World Health Organization
Professor Michael Baker, Department of Public Health University of Otago, New Zealand
Patrick Brennan, CEO, DetectED-X Professor, University of Sydney
Professor Datuk Dr. A.Rahman A.Jamal Head of Taskforce for MOSTI-MOHE COVID-19 Testing Laboratories
15:35 PM Panel Discussion: How Covid-19 is Accelerating the Adoption of Digital Technologies in Hospitals?
- Breaking down the latest technologies and solutions that are currently being used by healthcare providers to diagnose and combat COVID-19
- The role of AI powered mobile apps and chatbots in disseminating information related to COVID-19 infections
- Telemedicine or remote consultation for non-COVID 19 or non-acute patients
Panellists:
Dr Helmi Zakariah, Chief Executive Officer, AIME INC
Dr Snehal Patel, Chief Executive Officer & Co-Founder, MyDoc
Dr Md Khadzir bin Sheikh Hj. Ahmad, Deputy Director & Head Health Informatics Centre, Ministry of Health Malaysia
Dr Chris Bates, Director of Research and Analytics, TPP UK Digital Health Company
16:20 PM End of Webinar
|
SPONSORED BY:
ORGANIZED BY : 
|
|
